Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Tristan Baguet, PharmD
Janssen R&D, Belgium
Disclosure(s): Johnson&johnson: Stocks/Bonds (Public Company)
Poster(s):
(P-1104) Single-Dose and Repeat Single-Dose Ascending Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
